CCL2 and cancer: Significant differences in the circulating levels of serum IL-6, IL-8, IL-10, MCP-1 and IP-10 after three months of the nutritional intervention were observed in patients with head and neck cancer, neuroendocrine tumors, gastric, colon, urothelial or other types of cancer (Figure 4).